From Regal’s Phil King, who says stocks are nearing their bottom, to Airlie’s Emma Fisher, buying US-exposed equities, here ...

Shares of ResMed Inc. RMD slipped 3.97% to $204.54 Tuesday, on what proved to be an all-around poor trading session for the ...

In a welcome move, ResMed saw its Relative Strength Rating rise from 65 to 78 on Tuesday. Please watch the video at Investors ...

ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

If I had $10,000 to invest in the market today, I'd be looking for high-quality businesses that have fallen with the broader ...

Professional networking site LinkedIn has put together its annual list of Australia's best workplaces for career growth ...

Shares of ResMed Inc. RMD rallied 3.82% to $213.00 Monday, on what proved to be an all-around rough trading session for the ...

SAN DIEGO – Resmed has announced that its home sleep apnea test, NightOwl, is now available across the U.S.

Post Liberation Day, life science companies are clarifying the likely impact of Trump's tariffs – and the news is largely positive.

StockNews.com downgraded shares of ResMed (NYSE:RMD – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday morning. A number of other equities research ...

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.  | ...

A new Resmed-supported study showing sleep apnea patients on CPAP therapy live longer will further fuel a “once-in-a-generation opportunity” to increase awareness, says Carlos Nunez, ...